Lifevantage Corp (FRA:L2T1)
€ 6.7 -0.6 (-8.22%) Market Cap: 89.69 Mil Enterprise Value: 86.16 Mil PE Ratio: 27.46 PB Ratio: 3.64 GF Score: 63/100

LifeVantage Corp at ICR Conference (Virtual) Transcript

Jan 10, 2022 / 02:30PM GMT
Release Date Price: €5.7
Reed Anderson
ICR - Managing Director

Yes. Good morning, everyone, and I want to welcome you to the LifeVantage presentation at the 2022 ICR conference. LifeVantage is focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. Company is dedicated to helping people achieve their health, wellness and financial goals. LifeVantage offers a unique high-quality assortment of products that are scientifically validated and sold through a global network of independent distributors. Presenting for the Company are Steve Fife, the CEO; and Carl Aure, CFO. Welcome, gentlemen. Steve, I will turn it over to you.

Steve Fife
LifeVantage Corporation - President & CEO

Great, thank you so much, Reed, for that intro. And thank you, everyone, for listening in this morning to hear and learn a little bit more about LifeVantage. We are a publicly traded company on the NASDAQ, about $100 million in market cap. And as Reed just got through saying, we are a nutrigenomics company focusing on nutrition, health and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot